These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3102300)

  • 1. Tolrestat, an aldose reductase inhibitor, prevents nerve dysfunction in conscious diabetic rats.
    Notvest RR; Inserra JJ
    Diabetes; 1987 Apr; 36(4):500-4. PubMed ID: 3102300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat.
    Kemper C; Dvornik D
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.
    McCaleb ML; Sredy J; Millen J; Ackerman DM; Dvornik D
    J Diabet Complications; 1988; 2(1):16-8. PubMed ID: 2968349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.
    McCaleb ML; McKean ML; Hohman TC; Laver N; Robison WG
    Diabetologia; 1991 Oct; 34(10):695-701. PubMed ID: 1959701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration.
    Williamson JR; Chang K; Tilton RG; Prater C; Jeffrey JR; Weigel C; Sherman WR; Eades DM; Kilo C
    Diabetes; 1987 Jul; 36(7):813-21. PubMed ID: 3108058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of a new aldose reductase inhibitor (tolrestat) in galactosemic and diabetic rats.
    Simard-Duquesne N; Greselin E; Dubuc J; Dvornik D
    Metabolism; 1985 Oct; 34(10):885-92. PubMed ID: 3930915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO 2235.
    Yasuda H; Sonobe M; Yamashita M; Terada M; Hatanaka I; Huitian Z; Shigeta Y
    Diabetes; 1989 Jul; 38(7):832-8. PubMed ID: 2525492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB; Calcutt NA; Tomlinson DR
    Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre trial of the aldose-reductase inhibitor, tolrestat, in patients with symptomatic diabetic neuropathy.
    Boulton AJ; Levin S; Comstock J
    Diabetologia; 1990 Jul; 33(7):431-7. PubMed ID: 2119323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
    Sima AA; Greene DA; Brown MB; Hohman TC; Hicks D; Graepel GJ; Bochenek WJ; Beg M; Gonen B
    J Diabetes Complications; 1993; 7(3):157-69. PubMed ID: 8343610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA; Mackway AM
    Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
    J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J; Sawicki DR; Notvest RR
    J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE; Airey CM; Alani SM; Wales JK
    Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polyol pathway in retinal microangiopathy.
    Robison WG; Kinoshita JH; Kador PF
    Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
    Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldose reductase inhibitors in diabetic neuropathy].
    Erkelens DW; Bravenboer B
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):775-6. PubMed ID: 2110629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.